On November 7, 2025, in Beijing, China, @CenturyEggSoloCongee shared a video of a creative music-making session using everyday objects. In the video, the performer creates rhythmic sounds with a small ...

A motor retail group with a presence across the North West has lodged plans to transform a vacant commercial site in Rossendale into a car showroom, potentially providing employment for 90 people. Did ...

Aryan Juyal slammed an unbeaten 150 to steal the thunder from Sumit Ghadigaonkar as Uttar Pradesh registered a 58-run win over Assam via the VJD method in a rain-hit Vijay Hazare Trophy match to stay ...

The Oscar winner also says he doesn't like the immersive acting style "being misrepresented to the extent it has been." By Carly Thomas Associate Editor “Listen, I worked with Brian Cox once and got ...

Did you know that you can become a better runner by walking? Not only can walking play a significant role in aiding your overall health, but it can be an important part of your running journey, too.

ProShares UltraPro QQQ ETF offers significant long-term upside but comes with extreme volatility and risk due to its triple leverage. TQQQ can experience violent drawdowns in volatile markets but ...

Microsoft is removing more methods that help users create local Windows accounts and bypass the Microsoft account requirement when installing Windows 11. The change ...

Huawei’s Computing Systems Lab in Zurich has introduced a new open-source quantization method for large language models (LLMs) aimed at reducing memory demands without sacrificing output quality.

Astronomers have been fascinated after spotting an object earlier this year that came from interstellar space as is now hurtling through our inner solar system. Regardless, it’s an interesting visitor ...

RuneScape: Dragonwilds has a big new update that adds Creative Mode, with custom worlds and control over settings. The update also adds the Ranged skill for characters, with skills up to level 50, new ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.